A health care company is teaming up with life insurers to help solve what it calls “a $201 billion problem in America” – late-stage cancer treatment. Grail is a company on a mission to detect cancer ...
We examined no-exam coverage caps, costs and complaints ...
Large multi-institution PROSPR II study finds big gaps in access, timely care in cervical, colorectal and lung cancers across U.S. Cancer screening is incredibly beneficial, but only when it’s done ...
The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...
The American Cancer Society is now adding blood tests to its guidelines for colorectal cancer screening. But that doesn't mean you should skip your colonoscopy. In the updated guidelines, released May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results